[Ile31,Gln34]PP (human)



[Ile31,Gln34]PP (human)

A1AA1P2PP2L3LL3E4EE4P5PP5V6VV6Y7YY7P8PP8G9GG9D10DD10N11NN11A12AA12T13TT13P14PP14E15EE15Q16QQ16M17MM17A18AA18Q19QQ19Y20YY20A21AA21A22AA22D23DD23L24LL24R25RR25R26RR26Y27YY27I28II28N29NN29M30MM30I31II31T32TT32R33RR33Q34QQ34R35RR35Y36YY36

SMILES None
InChIKey None
Sequence APLEPVYPGDNATPEQMAQYAADLRRYINMITRQRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[Ile31,Gln34]PP (human)

A1AA1P2PP2L3LL3E4EE4P5PP5V6VV6Y7YY7P8PP8G9GG9D10DD10N11NN11A12AA12T13TT13P14PP14E15EE15Q16QQ16M17MM17A18AA18Q19QQ19Y20YY20A21AA21A22AA22D23DD23L24LL24R25RR25R26RR26Y27YY27I28II28N29NN29M30MM30I31II31T32TT32R33RR33Q34QQ34R35RR35Y36YY36

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.